Jeff Yass’s Apyx Medical APYX Stock Holding History

Jeff Yass’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,400	Closed	-$39.9K	–	13111
2025 Q4	$39.9K	Buy	+11,400	New	+$39.8K	﹤0.01%	11822
2022 Q4	–	Sell	-10,500	Closed	-$47K	–	12331
2022 Q3	$47K	Sell	10,500 -11,400	-52%	-$81.6K	﹤0.01%	12238
2022 Q2	$128K	Buy	+21,900	New	+$112K	﹤0.01%	11216
2019 Q2	–	Sell	-11,700	Closed	-$74K	–	10172
2019 Q1	$74K	Buy	+11,700	New	+$90.5K	﹤0.01%	8357
2017 Q4	–	Sell	-13,400	Closed	-$45K	–	9193
2017 Q3	$45K	Buy	+13,400	New	+$34.6K	﹤0.01%	8560
2017 Q2	–	Sell	-15,400	Closed	-$41K	–	9145
2017 Q1	$41K	Buy	+15,400	New	+$51.1K	﹤0.01%	8629

Other funds holding APYX

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jeff Yass's APYX Position: Q2 2026 in Review

Jeff Yass reduced its Apyx Medical (APYX) stake by 19% in Q2 2026, selling an estimated $203K and leaving 216,263 shares worth $971K. The position accounts for ﹤0.01% of the portfolio, ranked #8276.

Jeff Yass first reported a position in APYX in Q1 2016 and has held it in 24 quarters since. The position peaked at $1.3M in Q1 2019. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

Jeff Yass held 216,263 shares of Apyx Medical worth $971K as of Q2 2026.
Jeff Yass sold 51,298 Apyx Medical shares in Q2 2026, an estimated $203K.
Apyx Medical made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8276 holding.
Jeff Yass first reported a position in Apyx Medical in Q1 2016 and has held it in 24 quarters since.
Jeff Yass's Apyx Medical position peaked at $1.3M in Q1 2019.
68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.